The most researched is GHK-Cu, a naturally occurring peptide that declines significantly with age
It is not FDA-approved for anything and has no completed human clinical trials every effect below is preclinical (rodent/cell) only
hormone failure so as to [preserve] not only youthful anatomy but also youthful physiology.24 However, the Mayo Clinic warns that growth hormone therapy is a dubious treatment for age-related health conditions and notes that experts recommend against it.25 Sermorelin benefits Sermorelin increases growth hormone, which itself increases IGF-1, and together they have several positive health implications
Randomized comparison of thalidomide versus placebo in toxic epidermal necrolysis
Recombinant thrombomodulin protects against LPS-induced acute respiratory distress syndrome via preservation of pulmonary endothelial glycocalyx
Moreover, these drugs are often associated with side effects such as gastrointestinal distress, dizziness, and nausea, further limiting their long-term clinical utility ( 4.4 Socioeconomic burden and the need for cost-effective therapies Beyond its medical impact, AD imposes a substantial socioeconomic burden, affecting patients, caregivers, and healthcare systems
